![Ourania Tatsis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ourania Tatsis
Directeur/Membre du Conseil chez
ODYSSEY THERAPEUTICS, INC.
Fortune : 27 M $ au 30/06/2026
Profil
Ourania Tatsis currently works at Odyssey Therapeutics, Inc., as Independent Director from 2025, Vertex Pharmaceuticals, Inc., as Chief Regulatory & Quality Officer, Executive VP from 2020, and International Institute of New England, as Member-Leadership Council from 2021.
Dr. Tatsis also formerly worked at Verve Therapeutics, Inc., as Director from 2024 to 2025 and Genzyme Corp., as Vice President & Head-Global Regulatory Affairs from 2014 to 2017.
Dr. Tatsis received her undergraduate degree from Temple University (Pennsylvania) and doctorate degree from the University of Vermont.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/07/2026 | 53 572 ( 0,02 % ) | 27 M $ | 30/06/2026 |
Postes actifs de Ourania Tatsis
| Sociétés | Poste | Début |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 01/09/2017 |
| ODYSSEY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2025 |
International Institute of New England
 International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Corporate Officer/Principal | 01/01/2021 |
Anciens postes connus de Ourania Tatsis
| Sociétés | Poste | Fin |
|---|---|---|
| VERE THER | Directeur/Membre du Conseil | 25/07/2025 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2017 |
Formation de Ourania Tatsis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute of New England
International Institute of New England Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for immigration and foreign communities | Commercial Services |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
